|Series D, 5/12 |
Forbion Capital Partners
Oxford Bioscience Partners
Triathlon Medical Venture Partners
Johnson & Johnson Development Corporation
|Debt, 9/12 |
Horizon Technology Finance Management LLC
Mitralign is a venture backed privately held company located in a suburb of Boston, MA. The company is developing an innovative catheter based technology for percutaneous treatment of functional mitral regurgitation. The novel Mitralign system emulates surgical annuloplasty as it delivers a series of surgical implants directly into the mitral annulus by means of a catheter. The implants are cinched together, thus reducing the size of the mitral valve annulus and the valve opening.
Mitralign is funded by top tier venture capitalists and has two major cardiovascular device companies as investors.